1st Quarter - Amendment

ROCK & ASSOCIATES for BRAIDWOOD MANAGEMENT, INC.

Period 1st Quarter 2024 Filed May 8, 2024 Signed by James W. Rock

Official filing
Firm
ROCK & ASSOCIATES
Client
BRAIDWOOD MANAGEMENT, INC.
Income
$11,250
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations legislation related to FDA and compounding pharmacy.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Legislation relating to the regulation of compounding pharmacies. No specific legislation at this time.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Legislation relating to regulation of compounding pharmacies.

LobbyistCovered position, as disclosed
JAMES W ROCK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.